TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
about
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@en
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@nl
type
label
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@en
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@nl
prefLabel
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@en
TGF-beta Resistant Cytotoxic T ...... ryngeal Carcinoma / RESIST-NPC
@nl
P3098
NCT02065362